FDA: Prescribers can help stop false or misleading prescription drug promotion

FDA: Prescribers can help stop false or misleading prescription drug promotion

It is estimated that the pharmaceutical industry spent more than $24 billion on prescription drug promotion in 2017.Prescription drug promotion can provide prescribers with information about the latest drug therapies and may be part of their decision-making when treating patients. It is particularly important because it may inform prescribers’ assessments of the risks and benefits of a drug. The FDA needs your assistance in helping to ensure that this information is truthful and not misleading. Availability of such information contributes to quality patient care.For most prescriptionRead More

Share on facebook
Share on twitter
Share on linkedin